We use cookies to help us improve the website and your experience using it. You may delete and block all cookies from this site at any time. However, please note this may result in parts of the site no longer working correctly. If you continue without changing your settings we will assume you are happy to receive all cookies on this site.

Close

Citylabs: crane removal marks start of final phase

Citylabs4

The 100,000 sq ft Citylabs development is now reaching its final phase of construction, marked by the dismantling of the imposing tower crane today.

Work on the new build element is due to completed early next year, and the building is expected to open for business mid 2014 following the restoration of the former Royal Eye Hospital.

Biomedical companies choosing Citylabs will benefits from its location, at the heart of Europe's largest clinical academic campus. Companies based at Citylabs will be able to access expertise from within our hospitals and the wider Manchester Corridor.  This will give them a better understanding of patients' and clinicians' needs, and an opportunity to develop new medical technologies in a clinical setting to ensure that they are fit for purpose.

Central Manchester University Hospitals NHS Foundation Trust is a leading provider of tertiary and specialist healthcare services, and treats more than one million patients each year.  Our research is focused on better understanding a diverse range of conditions, including rare diseases, and we partner closely with The University of Manchester.  We manage over 800 clinical studies at any one time and, in 2012,  we were the second highest recruiting Trust in England, with over 20,000 patients recruited into studies.  We're committed to ensuring that patients get high quality of care now, but also recognise that it's important for us to work with others to conduct and apply research, to build better ways of working into our services for the future.

Citylabs1 Citylabs3 Citylabs2 Citylabs6 Citylabs5